These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2675381)

  • 1. [Side-effects of calcium inhibitors].
    Lavarenne J
    Therapie; 1989; 44(3):197-200. PubMed ID: 2675381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Side-effects of calcium antagonists].
    Fossati C; Guistiniani S
    Clin Ter; 1984 Jun; 109(6):569-74. PubMed ID: 6236948
    [No Abstract]   [Full Text] [Related]  

  • 5. The spectrum of cutaneous reactions associated with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms.
    Ioulios P; Charalampos M; Efrossini T
    Dermatol Online J; 2003 Dec; 9(5):6. PubMed ID: 14996379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropyridine calcium antagonists and the trough: peak ratio: focus on adverse effects.
    Myers MG
    J Hypertens Suppl; 1994 Nov; 12(8):S73-6; discussion S76-7. PubMed ID: 7707160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous adverse reactions associated with calcium channel blockers.
    Stern R; Khalsa JH
    Arch Intern Med; 1989 Apr; 149(4):829-32. PubMed ID: 2523214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and mechanisms of action of calcium-channel blockers.
    Katz AM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):28S-37S. PubMed ID: 3540226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side effects of calcium channel blockers.
    Russell RP
    Hypertension; 1988 Mar; 11(3 Pt 2):II42-4. PubMed ID: 3280492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular actions and pharmacology of the calcium channel blocking drugs.
    Katz AM; Hager WD; Messineo FC; Pappano AJ
    Am J Med; 1984 Aug; 77(2B):2-10. PubMed ID: 6486125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The spectrum of side effects of gallopamil in comparison with other calcium antagonists].
    Mildenberger D; Klepzig H; Hopf R; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():25-8. PubMed ID: 2698563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse effects of psychotropic agents].
    Owashi T; Kamijima K
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():247-53. PubMed ID: 18074545
    [No Abstract]   [Full Text] [Related]  

  • 16. [Calcium channel blockers (calcium antagonists). Background, effects and use].
    Mikkelsen EO
    Ugeskr Laeger; 1995 Jun; 157(26):3750-4. PubMed ID: 7631450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative review of the adverse effects of calcium antagonists.
    Dougall HT; McLay J
    Drug Saf; 1996 Aug; 15(2):91-106. PubMed ID: 8884161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers in the treatment of hypertension.
    Raspa RF; Wilson CC
    Am Fam Physician; 1993 Sep; 48(3):461-70. PubMed ID: 8362695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium antagonists in comparison: view of the pharmacologist.
    Borchard U
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S85-91. PubMed ID: 7898100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.